|
| Press Releases |
|
 |
|
| Friday, September 23, 2022 |
|
|
Malaysian Genomics Grows Presence in Thailand |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services. more info >> |
|
| Wednesday, September 21, 2022 |
|
|
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah |
| Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines. more info >> |
|
| Tuesday, August 30, 2022 |
|
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue |
| Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss of RM0.07 million in the corresponding quarter of the previous financial year (4Q 2021) on higher contribution from the biopharmaceutical business and continued organic growth of the genetic testing business. more info >> |
|
| Monday, August 29, 2022 |
|
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of Understanding (MoU) to explore opportunities for the distribution of biopharmaceutical and genomics products and services with Ajlan & Bros Medical Company. more info >> |
|
| Thursday, August 18, 2022 |
|
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU |
| Malaysian Genomics Resource Centre Berhad's (Bursa: MGRC, 0155) wholly-owned subsidiary, MGRC Therapeutics Sdn. Bhd. signed a memorandum of understanding (MoU) with MAHSA Health Sdn Bhd to discuss the formation of a strategic partnership promoting practice-based education, research and knowledge exchange. more info >> |
|
| Wednesday, July 20, 2022 |
|
|
UCrest Partners with Malaysian Genomics to Digitalize Genome Services Worldwide |
| UCrest Berhad (ACE Market: 0005) and Malaysian Genomics Resources Centre Berhad, (ACE Market: 0155) announced today that they have signed a collaborative agreement to integrate genomic testing services into digital health platform, iMedic(TM), elevating healthcare services to the next level. more info >> |
|
| Friday, July 15, 2022 |
|
|
Malaysian Genomics Appoints New Chairman |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Company has appointed Dato' Seri Dr Chen Chaw Min as the Independent Non-Executive Chairman of the Board of Directors. more info >> |
|
| Wednesday, July 13, 2022 |
|
|
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. more info >> |
|
| Friday, July 8, 2022 |
|
|
Malaysian Genomics Proposes Private Placement |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is proposing to undertake a private placement of up to 10% of its total number of issued shares or up to 12.42 million new placement shares at an issue price to be determined for third-party investors that will be identified later. more info >> |
|
| Wednesday, July 6, 2022 |
|
|
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles |
| Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group's wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRCT), is collaborating with Rinani Genotec Sdn Bhd (Genotec) to offer sports-based genetic tests. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Nanshan Aluminium International擬來港IPO
Oct 7, 2024 22:01 HKT/SGT
|
|
|
Nanshan Aluminium International拟来港IPO
Oct 7, 2024 21:35 HKT/SGT
|
|
|
Military Metals Enters into LOI to Acquire Two Antimony and One Tin Property in the European Union
Oct 7, 2024 20:39 HKT/SGT
|
|
|
32nd Edition of Digital Transformation Summit Announced by Exito Media Concepts
Oct 7, 2024 15:45 HKT/SGT
|
|
|
Unlocking India's Offshoring Advantage: Your Ultimate Guide for 2024
Oct 7, 2024 13:00 HKT/SGT
|
|
|
Indonesia's Path to Society 5.0: Driving Digital Innovation at the Digital Transformation Summit
Oct 7, 2024 10:40 HKT/SGT
|
|
|
JCB to offer Google Pay(TM) in Japan
Oct 7, 2024 11:00 JST
|
|
|
Success at the 9th Annual REITs and Real Estate Investment Summit Asia Pacific 2024(TM): Driving Profits Through Sustainable Technology and Net Zero Imperatives
Oct 7, 2024 09:00 HKT/SGT
|
|
|
BluWave-ai、特許件数を順調に拡大―米国特許商標庁に30件の特許を出願し、うち7件はすでに付与済み
Oct 7, 2024 08:00: JST
|
|
|
Antidote Announces $100M for Community Building and User Rewards
Oct 4, 2024 20:00: JST
|
|
|
Antidote Announces $100M for Community Building and User Rewards
Oct 4, 2024 19:00 HKT/SGT
|
|
|
CNNが人々の生活をつなぐ医療の未来を探る特別番組「Tomorrow Transformed」を放送
Oct 4, 2024 19:00: JST
|
|
|
Hong Kong Films @ Busan 2024 opens tomorrow
Oct 4, 2024 17:18 HKT/SGT
|
|
|
三菱重工、防衛省向け3,000トン型潜水艦「ちょうげい」の命名式・進水式を神戸造船所で実施
Oct 4, 2024 15:00: JST
|
|
|
Honda、「N-BOX」が2024年度上半期 新車販売台数 第1位を獲得
Oct 4, 2024 15:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
